Bristol Myers gets key FDA approval for bone marrow disease drug

Bristol Myers gets key FDA approval for bone marrow disease drug

Submitted by admin on August 30, 2023 - 9:54am
Source: 
BioPharma Dive
News Tags: 
Bristol Myers Squibb
FDA
Reblozyl
myelodysplastic syndromes
Headline: 
Bristol Myers gets key FDA approval for bone marrow disease drug
snippet: 

The expanded OK for Reblozyl in myelodysplastic syndromes could help the company offset looming patent cliffs for some of its top-selling medicines.

Do Not Allow Advertisers to Use My Personal information